Michael Offin Selected Research

Adjuvant Chemotherapy

8/2021

Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Offin Research Topics

Disease

34	Neoplasms (Cancer) 04/2024 - 01/2017
27	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2017
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2019
5	Adenocarcinoma of Lung 12/2021 - 08/2019
4	Mesothelioma 04/2024 - 12/2022
3	Disease Progression 11/2023 - 01/2020
3	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2020
3	Brain Neoplasms (Brain Tumor) 01/2020 - 10/2018
2	Melanoma (Melanoma, Malignant) 02/2024 - 01/2023
2	Malignant Mesothelioma 12/2023 - 01/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 12/2021
2	Carcinogenesis 01/2021 - 01/2021
1	Hypoxia (Hypoxemia) 04/2024
1	Fatigue 02/2024
1	Vomiting 02/2024
1	Nausea 02/2024
1	Diarrhea 02/2024
1	Skin Neoplasms (Skin Cancer) 02/2024
1	Fever (Fevers) 03/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	B-Cell Leukemia (Leukemia, B Cell) 01/2021
1	Radiation Pneumonitis 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Leukemia 10/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Wounds and Injuries (Trauma) 03/2015
1	Critical Illness (Critically Ill) 03/2015
1	Heart Arrest (Cardiac Arrest) 03/2015
1	Lung Injury 08/2011
1	Contusions 08/2011

Drug/Important Bio-Agent (IBA)

8	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
5	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 08/2019
5	durvalumabIBA 01/2023 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2018
4	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2019
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2020
3	Circulating Tumor DNAIBA 11/2022 - 01/2017
3	Cell-Free Nucleic AcidsIBA 08/2022 - 11/2019
3	osimertinibIBA 10/2021 - 01/2018
3	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2018
2	binimetinibIBA 02/2024 - 01/2023
2	encorafenibIBA 02/2024 - 01/2023
2	Phosphotransferases (Kinase)IBA 01/2022 - 08/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 10/2018
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2019 - 01/2019
2	human ERBB2 proteinIBA 12/2019 - 01/2018
1	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 04/2024
1	AsbestosIBA 04/2024
1	Oxygen (Dioxygen)IBA 04/2024
1	Pemetrexed (MTA)FDA Link 11/2023
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 11/2023
1	pembrolizumabIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	PlatinumIBA 11/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2022
1	Chimeric Antigen ReceptorsIBA 03/2022
1	MesothelinIBA 03/2022
1	selinexorIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	ParaffinIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	MTOR InhibitorsIBA 01/2021
1	LigandsIBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	CrizotinibIBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	trastuzumab deruxtecanIBA 01/2020
1	ORALIT (ORS)IBA 12/2019
1	Peptides (Polypeptides)IBA 10/2019
1	Cytidine DeaminaseIBA 10/2019
1	APOBEC-1 DeaminaseIBA 10/2019
1	Co-Repressor ProteinsIBA 10/2019
1	Codon (Codons)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 10/2018
1	Sunitinib (Sutent)FDA Link 10/2018
1	cabozantinibIBA 10/2018
1	vandetanib (ZD6474)IBA 10/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	entrectinibIBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2011

Therapy/Procedure

20	Therapeutics 11/2023 - 01/2017
5	Radiotherapy 02/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 11/2022 - 01/2022
2	Immunotherapy 01/2019 - 01/2019
1	Cryosurgery 04/2024
1	Continuity of Patient Care 08/2022
1	Adjuvant Chemotherapy 08/2021
1	Precision Medicine 01/2017
1	Resuscitation 03/2015